Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating an access or server issue loading the NCT03420521 page. The visible UI shows a simple header and a Home link, signaling restricted access to study details.
    Difference
    19%
    Check dated 2026-09-19T22:21:38.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.6, indicating a newer version of the page. This update appears to be a maintenance change rather than a modification to study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:29.000Z thumbnail image
  4. Check
    52 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.5) was added, and the previous revision tag (v3.6.4) removed. This reflects an internal update to the page version rather than changes to the study details or eligibility.
    Difference
    0.1%
    Check dated 2026-08-08T22:17:57.000Z thumbnail image
  5. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, reflecting a minor platform update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-25T13:12:55.000Z thumbnail image
  6. Check
    88 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.2 to v3.6.3, indicating a new release version. The change does not alter visible content.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:52.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page. This reflects a recent update to the page content or its presentation rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-26T23:23:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.